Recruitment - Articles
27-Aug-2010
A glimpse of the broad-based, versatile business strategy that has enabled Abbott to combine dynamic growth with long-term stability.
A glimpse of the broad-based, versatile business strategy that has enabled Abbott to combine dynamic growth with long-term stability. Abbott had an excellent 2004, according to its CEO, Miles White: it achieved double-digit growth in both of its business groups. How was this managed in the face of what is perhaps the most difficult business environment the healthcare industry has ever faced– and one that is not expected to improve significantly in the foreseeable future? How has Abbott navigated this extremely difficult environment while simultaneously transforming the company into anorganisation better prepared to overcome the same challenges in the futu…
A glimpse of the broad-based, versatile business strategy that has enabled Abbott to combine dynamic growth with long-term stability. Abbott had an excellent 2004, according to its CEO, Miles White: it achieved double-digit growth in both of its business groups. How was this managed in the face of what is perhaps the most difficult business environment the healthcare industry has ever faced– and one that is not expected to improve significantly in the foreseeable future? How has Abbott navigated this extremely difficult environment while simultaneously transforming the company into anorganisation better prepared to overcome the same challenges in the futu…
Abbott recently had the largest gain in reputation of any company in its industry
when Fortune magazine ranked it number three in the magazine’s list of the
most admired companies in the United States – Fortune’s highest ranking for
Abbott since 1989. How was this achieved and what factors led up to it?
Abbott recently had the largest gain in reputation of any company in its industry when Fortune magazine ranked it number three in the magazine’s list of the most admired companies in the – Fortune’s highest ranking for Abbott since 1989. How was this achieved and what factors led up to it? In April 2005, Miles White, Abbott’s CEO, summed up the previous year’s performance in one word – “Excellent”. Five years ago, it was clear that the company would have to reposition itself yet again in…
Abbott recently had the largest gain in reputation of any company in its industry when Fortune magazine ranked it number three in the magazine’s list of the most admired companies in the – Fortune’s highest ranking for Abbott since 1989. How was this achieved and what factors led up to it? In April 2005, Miles White, Abbott’s CEO, summed up the previous year’s performance in one word – “Excellent”. Five years ago, it was clear that the company would have to reposition itself yet again in…
27-Aug-2010
The early part of a New Year can be a good time to focus on your career and your personal goals for the coming year. You may be thinking of either looking for promotion within your current company or you may be thinking of applying to another company. Is there anything that you can do in order to increase your chances of being offered your dream job? The answer is yes, however it does need considerable input from you...
Of course before getting that crucial job offer there are the following hurdles to clear; your CV requires careful writing, there is pre-interview research to do and then the interview process itself to go through. You could stumble at any one of these hurdles. Checking these simple tips from the Vacancy Management Company can help you improve your chances of being offered…
Of course before getting that crucial job offer there are the following hurdles to clear; your CV requires careful writing, there is pre-interview research to do and then the interview process itself to go through. You could stumble at any one of these hurdles. Checking these simple tips from the Vacancy Management Company can help you improve your chances of being offered…
A new study shows the oral iron-chelator Ferriprox (deferiprone) prevents patients with thalassaemia experiencing heart complications and dying of heart failure. Patients with the condition require frequent blood transfusions with the unwanted effect of excess iron that can build up in organs and endocrine glands. Iron overload in the heart can produce fatal complications so effective treatment with iron chelation therapy to remove iron is vital. The finding that an oral treatment achieves bett
A new study shows the oral iron-chelator Ferriprox (deferiprone) prevents patients with thalassaemia experiencing heart complications and dying of heart failure. Patients with the condition require frequent blood transfusions with the unwanted effect of excess iron that can build up in organs…
A new study shows the oral iron-chelator Ferriprox (deferiprone) prevents patients with thalassaemia experiencing heart complications and dying of heart failure. Patients with the condition require frequent blood transfusions with the unwanted effect of excess iron that can build up in organs…
There is little mystery about what the next few years hold for the clinical research industry –it comes down to one word: speed. It is all about speed. The gauntlet has been thrown down and the companies that are able to demonstrate an effective and consistent approach to truncating the timeline of clinical trials will be very successful.
By: Brian S. Robinson i3, Vice-President, Global Marketing www.i3global.com There is little mystery about what the next few years hold for the clinical research industry –it comes down to one word: speed. It is all about speed. The gauntlet has been thrown down and the companies that are able to demonstrate an effective and consistent approach to truncating the timeline of clinical trials will be very successful. Speed is not a capabili…
By: Brian S. Robinson i3, Vice-President, Global Marketing www.i3global.com There is little mystery about what the next few years hold for the clinical research industry –it comes down to one word: speed. It is all about speed. The gauntlet has been thrown down and the companies that are able to demonstrate an effective and consistent approach to truncating the timeline of clinical trials will be very successful. Speed is not a capabili…
27-Aug-2010
Perhaps the greatest challenge facing global drug development is the scarcity of new clinical research professionals entering the industry, bringing refreshing energy and ideas to their work, but lacking practical experience. Those involved in recruiting CR staff will be aware of this shortage and that experienced employees are seeking greater career management/development and rapid progression.
Bill McHale and Iain Jessup – i3 Pharma Resourcing Perhaps the greatest challenge facing global drug development is the scarcity of new clinical research professionals entering the industry, bringing refreshing energy and ideas to their work, but lacking practical experience. Those involved in recruiting CR staff will be aware of this shortage and that experienced employees are seeking gr…
Bill McHale and Iain Jessup – i3 Pharma Resourcing Perhaps the greatest challenge facing global drug development is the scarcity of new clinical research professionals entering the industry, bringing refreshing energy and ideas to their work, but lacking practical experience. Those involved in recruiting CR staff will be aware of this shortage and that experienced employees are seeking gr…
27-Aug-2010
Electronic Data Capture (EDC), three little words that can divide the clinical research community like few others. To some, EDC is a panacea for all the troubles and rising costs of the clinical development process, whilst to others it spells broken promises, and forms the butt of many less than flattering anecdotes.
Electronic Data Capture (EDC), three little words that can divide the clinical research community like few others. To some, EDC is a panacea for all the troubles and rising costs of the clinical development process, whilst to others it spells broken promises, and forms the butt of many less than flattering anecdotes. But what is the reality, and where is the border between the promise of providers and the expectation of end users? This article is not designed to provide d…
Electronic Data Capture (EDC), three little words that can divide the clinical research community like few others. To some, EDC is a panacea for all the troubles and rising costs of the clinical development process, whilst to others it spells broken promises, and forms the butt of many less than flattering anecdotes. But what is the reality, and where is the border between the promise of providers and the expectation of end users? This article is not designed to provide d…
27-Aug-2010
Free Job Postings for UK Charity Organisations in the Healthcare Sector.
If you are a UK registered charity in the healthcare sector, we can offer you FREE job postings. So, you can access 160,000 visitors per month for nothing! If you want to know more contact Mike Wood
If you are a UK registered charity in the healthcare sector, we can offer you FREE job postings. So, you can access 160,000 visitors per month for nothing! If you want to know more contact Mike Wood
27-Aug-2010
New Blog for Jobs
As part of our continuing development and improvement, we have added created a Blog of our Top Jobs. This will be updated weekly and will also include any other news or information we think is relevant relevant to Pharmaceutical job searching. Check it out here: http://pharmaceuticaljobs.blogspot.com/
As part of our continuing development and improvement, we have added created a Blog of our Top Jobs. This will be updated weekly and will also include any other news or information we think is relevant relevant to Pharmaceutical job searching. Check it out here: http://pharmaceuticaljobs.blogspot.com/
New data presented at the American Society of Hematology meeting in Atlanta this month suggest the problems associated with iron overload in frequently-transfused patients can now be managed simply with an oral treatment rather than continuous infusions of several hours duration.
New data presented at the American Society of Hematology meeting in Atlanta this month suggest the problems associated with iron overload in frequently-transfused patients can now be managed simply with an oral treatment rather than continuous infusions of several hours duration. Iron was removed from the blood and tissues of patients just as safely and effectively with the novel once-daily oral chelator treatment deferasirox (Exjade) as with the standard older injectable iron chelator deferoxamine. Th…
New data presented at the American Society of Hematology meeting in Atlanta this month suggest the problems associated with iron overload in frequently-transfused patients can now be managed simply with an oral treatment rather than continuous infusions of several hours duration. Iron was removed from the blood and tissues of patients just as safely and effectively with the novel once-daily oral chelator treatment deferasirox (Exjade) as with the standard older injectable iron chelator deferoxamine. Th…
27-Aug-2010
Moving on inexorably carries with it the promise of ‘the farewell speech’...
There comes a time when we all have to move on, whether it be flying the parental coop to head off into the big wide world, breaking up with a lover or under threat of arrest outside the headquarters of the BBC after protesting at the recommissioning of popular ‘sitcom’, ‘Two Pints of Lager and a Packet of Crisps.’ And moving on inexorably carries with it the promise of ‘the farewell speech’. Like an ugly mate in a nightclub the farewell speech hangs around putting you off making the most of your potential but there’s no need for things to be that way, the farewell speech can not only pass off without incident, it can actually endear you to your ex-colleagues and make your superiors regret losing such a valuable em…
There comes a time when we all have to move on, whether it be flying the parental coop to head off into the big wide world, breaking up with a lover or under threat of arrest outside the headquarters of the BBC after protesting at the recommissioning of popular ‘sitcom’, ‘Two Pints of Lager and a Packet of Crisps.’ And moving on inexorably carries with it the promise of ‘the farewell speech’. Like an ugly mate in a nightclub the farewell speech hangs around putting you off making the most of your potential but there’s no need for things to be that way, the farewell speech can not only pass off without incident, it can actually endear you to your ex-colleagues and make your superiors regret losing such a valuable em…
27-Aug-2010
Clinical Research Academy (CRAcademy) has continued to find top candidates for Clinical Research Associate (CRA) posts by running a series of Selection and Assessment Days in the UK. The success of the first event led to a second in November 2005 where clients from the Pharmaceutical and Clinical Research industry joined the panel at interview.
Clinical Research Academy (CRAcademy) has continued to find top candidates for Clinical Research Associate (CRA) posts by running a series of Selection and Assessment Days in the UK. The success of the first event led to a second in November 2005 where clients from the Pharmaceutical and Clinical Research industry joined the panel at interview. The 23 candidates were chosen from over 70 applicants who expressed a desire to become Clinical Research As…
Clinical Research Academy (CRAcademy) has continued to find top candidates for Clinical Research Associate (CRA) posts by running a series of Selection and Assessment Days in the UK. The success of the first event led to a second in November 2005 where clients from the Pharmaceutical and Clinical Research industry joined the panel at interview. The 23 candidates were chosen from over 70 applicants who expressed a desire to become Clinical Research As…
27-Aug-2010
The end of year appraisal is something that many people dread, some people think that it is a complete waste of time and while others actually look forward to it. Which one of the previous descriptions fits you the best?
The end of year appraisal is something that many people dread, some people think that it is a complete waste of time and while others actually look forward to it. Which one of the previous descriptions fits you the best? If you and your manager have been having regular contact during 2005 then your end of year appraisal should have no surprises in it. It is a time that you can sparkle if you have put enough effort into your work over the proceeding year. The appraisal interview should be quality time that you have with your manager when you can revisit your successes and ac…
The end of year appraisal is something that many people dread, some people think that it is a complete waste of time and while others actually look forward to it. Which one of the previous descriptions fits you the best? If you and your manager have been having regular contact during 2005 then your end of year appraisal should have no surprises in it. It is a time that you can sparkle if you have put enough effort into your work over the proceeding year. The appraisal interview should be quality time that you have with your manager when you can revisit your successes and ac…
27-Aug-2010
Personality tests are commonly at interviews to calculate your personality "Type". It is likely that you will be faced with one during your career.
Personality tests are commonly at interviews to calculate your personality "Type". It is likely that you will be faced with one during your career. Understanding about personality tests can be a big help should you have to face one and the best way to understand them is to do one. (You try one here for free. http://www.peoplemaps.com )Your personality test results will reveal a range of things about you to a potential employer. Typically it will reveal your strengths, weaknesses and your preferred style of working and communicating. To begin with you will usually be asked to complete a Forced Choice Questionnaire if it is a sophisticated system…
Personality tests are commonly at interviews to calculate your personality "Type". It is likely that you will be faced with one during your career. Understanding about personality tests can be a big help should you have to face one and the best way to understand them is to do one. (You try one here for free. http://www.peoplemaps.com )Your personality test results will reveal a range of things about you to a potential employer. Typically it will reveal your strengths, weaknesses and your preferred style of working and communicating. To begin with you will usually be asked to complete a Forced Choice Questionnaire if it is a sophisticated system…
Abbott Diabetes Care today introduced the new Precision Xtra™ Plus (Optium™ Plus in some markets) Glucose Test Strip in Europe for use with the Precision™ Xceed (Optium Xceed™ in some markets) Advanced Diabetes Management System at the 41st Annual Meeting of the European Association for the Study of Diabetes in Athens, Greece. The new test strip offers results in just five seconds and requires a small blood sample of only 0.6 micro litre. The new Precision Xtra Plus test strip provides reliabl
Athens, Greece, September 13, 2005 — Abbott Diabetes Care today introduced the new Precision Xtra™ Plus (Optium™ Plus in some markets) Glucose Test Strip in Europe for use with the Precision™ Xceed (Optium Xceed™ in some markets) Advanced Diabetes Management System at the 41st Annual Meeting of the…
Athens, Greece, September 13, 2005 — Abbott Diabetes Care today introduced the new Precision Xtra™ Plus (Optium™ Plus in some markets) Glucose Test Strip in Europe for use with the Precision™ Xceed (Optium Xceed™ in some markets) Advanced Diabetes Management System at the 41st Annual Meeting of the…
Dronedarone, a new Class III multi-channel blocking anti-arrhythmic drug currently in Phase III development by Sanofi-Aventis for the prevention of atrial fibrillation (AF) and atrial flutter (AFL) may help fill the unmet need for a safe pharmacologic treatment that effectively controls atrial fibrillation, cardiologists said this month. Sanofi-Aventis presented new data on dronedarone at the American Heart Association’s (AHA) annual scientific sessions held in Dallas.
Dronedarone, a new Class III multi-channel blocking anti-arrhythmic drug currently in Phase III development by Sanofi-Aventis for the prevention of atrial fibrillation (AF) and atrial flutter (AFL) may help fill the unmet need for a safe pharmacologic treatment that effectively controls atrial fibrillation, cardiologists sa…
Dronedarone, a new Class III multi-channel blocking anti-arrhythmic drug currently in Phase III development by Sanofi-Aventis for the prevention of atrial fibrillation (AF) and atrial flutter (AFL) may help fill the unmet need for a safe pharmacologic treatment that effectively controls atrial fibrillation, cardiologists sa…
Patients who could benefit from injectable therapies are a lot less needle-phobic than doctors assume, according to research conducted by pharmacist and behavioural scientist Professor Robert Horne. The “Open Mind” study presented at the 10th European AIDS Conference/EACS in Dublin showed over three quarters of patients would be willing to accept self-administered subcutaneous injectable therapy if offered.
Patients who could benefit from injectable therapies are a lot less needle-phobic than doctors assume, according to research conducted by pharmacist and behavioural scientist Professor Robert Horne. The “Open Mind” study presented at the 10th European AIDS Conference/EACS in Dublin showed over three quarters of patients would be willing to accept self-administered subcutane…
Patients who could benefit from injectable therapies are a lot less needle-phobic than doctors assume, according to research conducted by pharmacist and behavioural scientist Professor Robert Horne. The “Open Mind” study presented at the 10th European AIDS Conference/EACS in Dublin showed over three quarters of patients would be willing to accept self-administered subcutane…
In the first article on acquisitions and joint ventures, we saw how despite the odds on an acquisition adding value for shareholders being only one in three, companies like Johnson & Johnson, Pfizer, Sosei and Amphion Innovations are still racing ahead. Now we take a glimpse at the similarly challenging world of joint ventures – and then look at how companies can increase the odds with a little forward planning.
Improving the odds for acquisitions and joint ventures Part II In the first article on acquisitions and joint ventures, we saw how despite the odds on an acquisition adding value for shareholders being only one in three, companies like Johnson & Johnson, Pfizer, Sosei and Amphion Innovations are still racing ahead. Now we take a glimpse at the similarly challenging…
Improving the odds for acquisitions and joint ventures Part II In the first article on acquisitions and joint ventures, we saw how despite the odds on an acquisition adding value for shareholders being only one in three, companies like Johnson & Johnson, Pfizer, Sosei and Amphion Innovations are still racing ahead. Now we take a glimpse at the similarly challenging…
27-Aug-2010
Caution: Your CV is your personal data. My advice as a recruiter, with many years experience in the clinical research industry, would be to take care where you send your CV and make sure your data is treated with the respect it deserves! The important thing is to be selective.
Recruitment websites can be confusing, strange places to the inexperienced. If you are not sure, select an established agency with a name you recognise. Follow the link to their website and find a contact name. Email or phone them to ask for advice. If the website doesn’t give you information about their recruiters, maybe it is best to give them a miss. Using the internet is supposed to be speedy and convenient. However, a common complaint we hear is that sending off a CV to some recruitm…
Recruitment websites can be confusing, strange places to the inexperienced. If you are not sure, select an established agency with a name you recognise. Follow the link to their website and find a contact name. Email or phone them to ask for advice. If the website doesn’t give you information about their recruiters, maybe it is best to give them a miss. Using the internet is supposed to be speedy and convenient. However, a common complaint we hear is that sending off a CV to some recruitm…
27-Aug-2010
e-Detailing is one of the pharmaceutical industry's biggest buzz terms of the moment, but it is one that, for the moment at least, seems unlikely to go away. This informative paper will help you under
By Dr. Andre Bates, Originally Published in International Journal of Medical Marketing, May 2002, Vol 2 Number 3 Abstract: eDetailing is currently under consideration by many pharmaceutical companies as a way to maximise sales force time, cut costs and increase physician prescribing. eDetailing is not a single entity but can take many different forms: from remote live discussion with a sales rep to a purely scripted interaction with a web site or an Interactive Voice Response phone line. Most eDetailing models have been tried in the US and only some models such as some forms of Scripted eDeta…
By Dr. Andre Bates, Originally Published in International Journal of Medical Marketing, May 2002, Vol 2 Number 3 Abstract: eDetailing is currently under consideration by many pharmaceutical companies as a way to maximise sales force time, cut costs and increase physician prescribing. eDetailing is not a single entity but can take many different forms: from remote live discussion with a sales rep to a purely scripted interaction with a web site or an Interactive Voice Response phone line. Most eDetailing models have been tried in the US and only some models such as some forms of Scripted eDeta…
